Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

SCAP siRNA Oligos set (Human)

Product Specifications

Gene Name

SCAP

Gene Aliases

KIAA0199

Accession Number

NM_012235

Origin

Human

Format

Lyophilized Powder

Shipping Conditions

Ambient Temperature

Storage Conditions

Upon receipt, -70°C for long term storage; -20°C for short term storage. Recommended storage concentration is above 20μM. After reconstitution, store in aliquots to avoid repeated freeze-thawing.
Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca
OR1074670-01 10 mg

Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca

Ask
View Details
Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca
OR1074670-02 25 mg

Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca

Ask
View Details
Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca
OR1074670-03 50 mg

Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca

Ask
View Details
Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca
OR1074670-04 100 mg

Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca

Ask
View Details
Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca
OR1074670-05 250 mg

Rel- ((1R,8S,9s) -Bicyclo[6.1.0]non-4-yn-9-yl) methyl ((S) -14- ((2S,4R) -4-hydroxy-2- ((4- (4-methylthiazol-5-yl) benzyl) carbamoyl) pyrrolidine-1-carbonyl) -15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl) ca

Ask
View Details
PPM1N CRISPR Activation Plasmid (h)
sc-409046-ACT 20 µg

PPM1N CRISPR Activation Plasmid (h)

Ask
View Details